Skip to content

Effects of Ketamine on Human Bladders and Its Possible Mechanisms

Effects of Ketamine on Human Bladders and Its Possible Mechanisms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00957333
Enrollment
44
Registered
2009-08-12
Start date
2009-03-31
Completion date
2011-12-31
Last updated
2016-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystitis

Keywords

ketamine, bladder dysfunction, bladder mucosa, mechanisms

Brief summary

This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.

Interventions

OTHERketamine

Sponsors

Taipei Medical University WanFang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult male or female * Cystitis (the clinicians ruled out the causes of bacterial infection) * Frequent micturition * The clinicians are willing to sign the ICF

Exclusion criteria

* Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling * Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling * The clinicians are not willing to sign the ICF

Design outcomes

Primary

MeasureTime frameDescription
Substance Abuse Situation Record1 daySubstance abuse situation record: ketamine

Secondary

MeasureTime frame
Urinary Bladder Capacity1 day

Countries

Taiwan

Participant flow

Participants by arm

ArmCount
Case
ketamine + Cystitis ketamine
44
Total44

Baseline characteristics

CharacteristicCase
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants
Age, Continuous28 years
STANDARD_DEVIATION 6
Region of Enrollment
Taiwan
44 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
27 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 44
serious
Total, serious adverse events
0 / 44

Outcome results

Primary

Substance Abuse Situation Record

Substance abuse situation record: ketamine

Time frame: 1 day

ArmMeasureValue (MEAN)
CaseSubstance Abuse Situation Record2 years
Secondary

Urinary Bladder Capacity

Time frame: 1 day

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026